<DOC>
	<DOC>NCT00033033</DOC>
	<brief_summary>The purpose of this study is to assess the efficacy and safety of reserpine for the treatment of cocaine dependence.</brief_summary>
	<brief_title>Reserpine for the Treatment of Cocaine Dependence - 1</brief_title>
	<detailed_description>To assess the efficacy and safety of reserpine in reducing cocaine use in subjects with cocaine dependence. This is a double-blind, placebo-controlled, parallel-group design with a 2 week baseline period.</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<mesh_term>Reserpine</mesh_term>
	<criteria>Be at least 18 yrs of age; DSM4 diagnosis of cocaine dependence; treatment seeking individuals; have the ability to understand and provide written informed consent; females of child bearing potential using appropriate birth control method Additional criteria available during screening at the site.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>cocaine dependence</keyword>
</DOC>